Skip to main content
Erschienen in: Journal of Cardiovascular Translational Research 1/2017

29.12.2016 | Original Article

Non classical Monocytes Levels, Increased by Subcutaneous Fat-Secretome, Are Associated with Less Rehospitalization after Heart Failure Admission

verfasst von: Sonia Eiras, Alfonso Varela-Román, Mariléia Cháves Andrade, Ana Castro, Rocío González-Ferreiro, Juan E. Viñuela, Ángel Fernández-Trasancos, Marcos C Carreira, Ezequiel Álvarez, Felipe F Casanueva, José R González-Juanatey

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Differential monocyte subsets are increased in obesity and heart failure (HF). We studied their role as predictors of rehospitalization for HF and their regulation by adipose tissue. Monocyte subsets and body fat composition were determined from 136 patients at the discharge after HF admission. Regulation of monocytes by SAT secretomes from obese/non-obese patients with HF was studied in a cell culture method. Proteomic analysis of secretome SAT was performed by LC-MALDI TOF/TOF. High CD14CD16+ monocyte levels indicated less rehospitalization for HF (p = 0.018). SAT secretomes from obese patients increased the CD14CD16+monocytes (11.8 ± 5.3 vs 3.9 ± 2.6%; p < 0.01). Differential proteins were determined between obese and non-obese patients with HF. High levels of CD14CD16+ monocytes are associated with less rehospitalization for HF. This phenotype is upregulated by SAT secretome from obese patients with HF. This mechanism might help us to understand the obesity paradox in HF.
Literatur
1.
Zurück zum Zitat Dunlay, S. M., Redfield, M. M., Weston, S. A., Therneau, T. M., Hall Long, K., Shah, N. D., & Roger, V. L. (2009). Hospitalizations after heart failure diagnosis a community perspective. Journal of the American College of Cardiology, 54, 1695–1702.CrossRefPubMedPubMedCentral Dunlay, S. M., Redfield, M. M., Weston, S. A., Therneau, T. M., Hall Long, K., Shah, N. D., & Roger, V. L. (2009). Hospitalizations after heart failure diagnosis a community perspective. Journal of the American College of Cardiology, 54, 1695–1702.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Cleland, J. G., Chiswell, K., Teerlink, J. R., Stevens, S., Fiuzat, M., Givertz, M. M., Davison, B. A., Mansoor, G. A., Ponikowski, P., Voors, A. A., Cotter, G., Metra, M., Massie, B. M., & O'Connor, C. M. (2014). Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the placebo-controlled randomized study of the selective A1 adenosine receptor antagonist Rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function (PROTECT) study. Circulation. Heart Failure, 7, 76–87.CrossRefPubMed Cleland, J. G., Chiswell, K., Teerlink, J. R., Stevens, S., Fiuzat, M., Givertz, M. M., Davison, B. A., Mansoor, G. A., Ponikowski, P., Voors, A. A., Cotter, G., Metra, M., Massie, B. M., & O'Connor, C. M. (2014). Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the placebo-controlled randomized study of the selective A1 adenosine receptor antagonist Rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function (PROTECT) study. Circulation. Heart Failure, 7, 76–87.CrossRefPubMed
3.
Zurück zum Zitat O'Connor, C. M., Abraham, W. T., Albert, N. M., Clare, R., Gattis Stough, W., Gheorghiade, M., Greenberg, B. H., Yancy, C. W., Young, J. B., & Fonarow, G. C. (2008). Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF). American Heart Journal, 156, 662–673.CrossRefPubMed O'Connor, C. M., Abraham, W. T., Albert, N. M., Clare, R., Gattis Stough, W., Gheorghiade, M., Greenberg, B. H., Yancy, C. W., Young, J. B., & Fonarow, G. C. (2008). Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF). American Heart Journal, 156, 662–673.CrossRefPubMed
4.
Zurück zum Zitat Lavie, C. J., Osman, A. F., Milani, R. V., & Mehra, M. R. (2003). Body composition and prognosis in chronic systolic heart failure: the obesity paradox. The American Journal of Cardiology, 91, 891–894.CrossRefPubMed Lavie, C. J., Osman, A. F., Milani, R. V., & Mehra, M. R. (2003). Body composition and prognosis in chronic systolic heart failure: the obesity paradox. The American Journal of Cardiology, 91, 891–894.CrossRefPubMed
5.
Zurück zum Zitat Horwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R., Woo, M. A., & Tillisch, J. H. (2001). The relationship between obesity and mortality in patients with heart failure. Journal of the American College of Cardiology, 38, 789–795.CrossRefPubMed Horwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R., Woo, M. A., & Tillisch, J. H. (2001). The relationship between obesity and mortality in patients with heart failure. Journal of the American College of Cardiology, 38, 789–795.CrossRefPubMed
6.
Zurück zum Zitat Hall, J. A., French, T. K., Rasmusson, K. D., Vesty, J. C., Roberts, C. A., Rimmasch, H. L., Kfoury, A. G., & Renlund, D. G. (2005). The paradox of obesity in patients with heart failure. Journal of the American Academy of Nurse Practitioners, 17, 542–546.CrossRefPubMed Hall, J. A., French, T. K., Rasmusson, K. D., Vesty, J. C., Roberts, C. A., Rimmasch, H. L., Kfoury, A. G., & Renlund, D. G. (2005). The paradox of obesity in patients with heart failure. Journal of the American Academy of Nurse Practitioners, 17, 542–546.CrossRefPubMed
7.
Zurück zum Zitat Lavie, C. J., Sharma, A., Alpert, M. A., De Schutter, A., Lopez-Jimenez, F., Milani, R. V., & Ventura, H. O. (2016). Update on obesity and obesity paradox in heart failure. Progress in Cardiovascular Diseases, 58, 393–400.CrossRefPubMed Lavie, C. J., Sharma, A., Alpert, M. A., De Schutter, A., Lopez-Jimenez, F., Milani, R. V., & Ventura, H. O. (2016). Update on obesity and obesity paradox in heart failure. Progress in Cardiovascular Diseases, 58, 393–400.CrossRefPubMed
8.
Zurück zum Zitat Lavie, C. J., Milani, R. V., & Ventura, H. O. (2009). Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. Journal of the American College of Cardiology, 53, 1925–1932.CrossRefPubMed Lavie, C. J., Milani, R. V., & Ventura, H. O. (2009). Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. Journal of the American College of Cardiology, 53, 1925–1932.CrossRefPubMed
9.
Zurück zum Zitat Lavie, C. J., De Schutter, A., Parto, P., Jahangir, E., Kokkinos, P., Ortega, F. B., Arena, R., & Milani, R. V. (2016). Obesity and prevalence of cardiovascular diseases and prognosis-the obesity paradox updated. Progress in Cardiovascular Diseases, 58, 537–547.CrossRefPubMed Lavie, C. J., De Schutter, A., Parto, P., Jahangir, E., Kokkinos, P., Ortega, F. B., Arena, R., & Milani, R. V. (2016). Obesity and prevalence of cardiovascular diseases and prognosis-the obesity paradox updated. Progress in Cardiovascular Diseases, 58, 537–547.CrossRefPubMed
10.
Zurück zum Zitat Reilly, S. M., & Saltiel, A. R. (2014). Obesity: a complex role for adipose tissue macrophages. Nature Reviews. Endocrinology, 10, 193–194.CrossRefPubMed Reilly, S. M., & Saltiel, A. R. (2014). Obesity: a complex role for adipose tissue macrophages. Nature Reviews. Endocrinology, 10, 193–194.CrossRefPubMed
11.
Zurück zum Zitat Ancuta, P., Rao, R., Moses, A., Mehle, A., Shaw, S. K., Luscinskas, F. W., & Gabuzda, D. (2003). Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. The Journal of Experimental Medicine, 197, 1701–1707.CrossRefPubMedPubMedCentral Ancuta, P., Rao, R., Moses, A., Mehle, A., Shaw, S. K., Luscinskas, F. W., & Gabuzda, D. (2003). Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. The Journal of Experimental Medicine, 197, 1701–1707.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Amir, O., Spivak, I., Lavi, I., & Rahat, M. A. (2012). Changes in the monocytic subsets CD14(dim)CD16(+) and CD14(++)CD16(−) in chronic systolic heart failure patients. Mediators of Inflammation, 2012, 616384.CrossRefPubMedPubMedCentral Amir, O., Spivak, I., Lavi, I., & Rahat, M. A. (2012). Changes in the monocytic subsets CD14(dim)CD16(+) and CD14(++)CD16(−) in chronic systolic heart failure patients. Mediators of Inflammation, 2012, 616384.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Berg, K. E., Ljungcrantz, I., Andersson, L., Bryngelsson, C., Hedblad, B., Fredrikson, G. N., Nilsson, J., & Bjorkbacka, H. (2012). Elevated CD14++CD16- monocytes predict cardiovascular events. Circulation. Cardiovascular Genetics, 5, 122–131.CrossRefPubMed Berg, K. E., Ljungcrantz, I., Andersson, L., Bryngelsson, C., Hedblad, B., Fredrikson, G. N., Nilsson, J., & Bjorkbacka, H. (2012). Elevated CD14++CD16- monocytes predict cardiovascular events. Circulation. Cardiovascular Genetics, 5, 122–131.CrossRefPubMed
14.
Zurück zum Zitat Belge, K. U., Dayyani, F., Horelt, A., Siedlar, M., Frankenberger, M., Frankenberger, B., Espevik, T., & Ziegler-Heitbrock, L. (2002). The proinflammatory CD14 + CD16 + DR++ monocytes are a major source of TNF. Journal of Immunology, 168, 3536–3542.CrossRef Belge, K. U., Dayyani, F., Horelt, A., Siedlar, M., Frankenberger, M., Frankenberger, B., Espevik, T., & Ziegler-Heitbrock, L. (2002). The proinflammatory CD14 + CD16 + DR++ monocytes are a major source of TNF. Journal of Immunology, 168, 3536–3542.CrossRef
15.
Zurück zum Zitat Rogacev, K. S., Ulrich, C., Blomer, L., Hornof, F., Oster, K., Ziegelin, M., Cremers, B., Grenner, Y., Geisel, J., Schlitt, A., Kohler, H., Fliser, D., Girndt, M., & Heine, G. H. (2009). Monocyte heterogeneity in obesity and subclinical atherosclerosis. European Heart Journal, 31, 369–376.CrossRefPubMed Rogacev, K. S., Ulrich, C., Blomer, L., Hornof, F., Oster, K., Ziegelin, M., Cremers, B., Grenner, Y., Geisel, J., Schlitt, A., Kohler, H., Fliser, D., Girndt, M., & Heine, G. H. (2009). Monocyte heterogeneity in obesity and subclinical atherosclerosis. European Heart Journal, 31, 369–376.CrossRefPubMed
16.
Zurück zum Zitat Barisione, C., Garibaldi, S., Ghigliotti, G., Fabbi, P., Altieri, P., Casale, M. C., Spallarossa, P., Bertero, G., Balbi, M., Corsiglia, L., & Brunelli, C. (2010). CD14CD16 monocyte subset levels in heart failure patients. Disease Markers, 28, 115–124.CrossRefPubMedPubMedCentral Barisione, C., Garibaldi, S., Ghigliotti, G., Fabbi, P., Altieri, P., Casale, M. C., Spallarossa, P., Bertero, G., Balbi, M., Corsiglia, L., & Brunelli, C. (2010). CD14CD16 monocyte subset levels in heart failure patients. Disease Markers, 28, 115–124.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Poitou, C., Dalmas, E., Renovato, M., Benhamo, V., Hajduch, F., Abdennour, M., Kahn, J. F., Veyrie, N., Rizkalla, S., Fridman, W. H., Sautes-Fridman, C., Clement, K., & Cremer, I. (2015). CD14dimCD16+ and CD14 + CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 2322–2330.CrossRef Poitou, C., Dalmas, E., Renovato, M., Benhamo, V., Hajduch, F., Abdennour, M., Kahn, J. F., Veyrie, N., Rizkalla, S., Fridman, W. H., Sautes-Fridman, C., Clement, K., & Cremer, I. (2015). CD14dimCD16+ and CD14 + CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 2322–2330.CrossRef
18.
Zurück zum Zitat Stults-Kolehmainen, M. A., Stanforth, P. R., Bartholomew, J. B., Lu, T., Abolt, C. J., & Sinha, R. (2013). DXA estimates of fat in abdominal, trunk and hip regions varies by ethnicity in men. Nutr Diabetes, 3, e64.CrossRefPubMedPubMedCentral Stults-Kolehmainen, M. A., Stanforth, P. R., Bartholomew, J. B., Lu, T., Abolt, C. J., & Sinha, R. (2013). DXA estimates of fat in abdominal, trunk and hip regions varies by ethnicity in men. Nutr Diabetes, 3, e64.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Lage, R., Moscoso, I., Fernandez-Trasancos, A., Cebro, M., Couselo, M., Fandino-Vaquero, R., Bravo, S. B., Sierra, J., Gonzalez-Juanatey, J. R., & Eiras, S. (2015). Differential behaviour of epicardial adipose tissue-secretomes with high and low orosomucoid levels from patients with cardiovascular disease in H9C2 cells. Molecular and Cellular Endocrinology, 416, 77–87.CrossRefPubMed Lage, R., Moscoso, I., Fernandez-Trasancos, A., Cebro, M., Couselo, M., Fandino-Vaquero, R., Bravo, S. B., Sierra, J., Gonzalez-Juanatey, J. R., & Eiras, S. (2015). Differential behaviour of epicardial adipose tissue-secretomes with high and low orosomucoid levels from patients with cardiovascular disease in H9C2 cells. Molecular and Cellular Endocrinology, 416, 77–87.CrossRefPubMed
20.
Zurück zum Zitat Pathan, M., Keerthikumar, S., Ang, C. S., Gangoda, L., Quek, C. Y., Williamson, N. A., Mouradov, D., Sieber, O. M., Simpson, R. J., Salim, A., Bacic, A., Hill, A. F., Stroud, D. A., Ryan, M. T., Agbinya, J. I., Mariadason, J. M., Burgess, A. W., & Mathivanan, S. (2015). FunRich: an open access standalone functional enrichment and interaction network analysis tool. Proteomics, 15, 2597–2601.CrossRefPubMed Pathan, M., Keerthikumar, S., Ang, C. S., Gangoda, L., Quek, C. Y., Williamson, N. A., Mouradov, D., Sieber, O. M., Simpson, R. J., Salim, A., Bacic, A., Hill, A. F., Stroud, D. A., Ryan, M. T., Agbinya, J. I., Mariadason, J. M., Burgess, A. W., & Mathivanan, S. (2015). FunRich: an open access standalone functional enrichment and interaction network analysis tool. Proteomics, 15, 2597–2601.CrossRefPubMed
21.
Zurück zum Zitat Kaufmann, A., Salentin, R., Gemsa, D., & Sprenger, H. (2001). Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. Journal of Leukocyte Biology, 69, 248–252.PubMed Kaufmann, A., Salentin, R., Gemsa, D., & Sprenger, H. (2001). Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. Journal of Leukocyte Biology, 69, 248–252.PubMed
22.
Zurück zum Zitat Melenovsky, V., Kotrc, M., Borlaug, B. A., Marek, T., Kovar, J., Malek, I., & Kautzner, J. (2013). Relationships between right ventricular function, body composition, and prognosis in advanced heart failure. Journal of the American College of Cardiology, 62, 1660–1670.CrossRefPubMed Melenovsky, V., Kotrc, M., Borlaug, B. A., Marek, T., Kovar, J., Malek, I., & Kautzner, J. (2013). Relationships between right ventricular function, body composition, and prognosis in advanced heart failure. Journal of the American College of Cardiology, 62, 1660–1670.CrossRefPubMed
23.
Zurück zum Zitat Teijeira-Fernandez, E., Eiras, S., Salgado Somoza, A., & Gonzalez-Juanatey, J. R. (2012). Baseline epicardial adipose tissue adiponectin levels predict cardiovascular outcomes: a long-term follow-up study. Cytokine, 60, 674–680.CrossRefPubMed Teijeira-Fernandez, E., Eiras, S., Salgado Somoza, A., & Gonzalez-Juanatey, J. R. (2012). Baseline epicardial adipose tissue adiponectin levels predict cardiovascular outcomes: a long-term follow-up study. Cytokine, 60, 674–680.CrossRefPubMed
24.
Zurück zum Zitat Roca-Rivada, A., Belen Bravo, S., Perez-Sotelo, D., Alonso, J., Castro, A. I., Baamonde, I., Baltar, J., Casanueva, F. F., & Pardo, M. (2015). CILAIR-based secretome analysis of obese visceral and subcutaneous adipose tissues reveals distinctive ECM remodeling and inflammation mediators. Scientific Reports, 5, 12214.CrossRefPubMedPubMedCentral Roca-Rivada, A., Belen Bravo, S., Perez-Sotelo, D., Alonso, J., Castro, A. I., Baamonde, I., Baltar, J., Casanueva, F. F., & Pardo, M. (2015). CILAIR-based secretome analysis of obese visceral and subcutaneous adipose tissues reveals distinctive ECM remodeling and inflammation mediators. Scientific Reports, 5, 12214.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Tanko, L. B., Bagger, Y. Z., Alexandersen, P., Larsen, P. J., & Christiansen, C. (2003). Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation, 107, 1626–1631.CrossRefPubMed Tanko, L. B., Bagger, Y. Z., Alexandersen, P., Larsen, P. J., & Christiansen, C. (2003). Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation, 107, 1626–1631.CrossRefPubMed
26.
Zurück zum Zitat Guglin, M., Baxi, K., & Schabath, M. (2014). Anatomy of the obesity paradox in heart failure. Heart Failure Reviews, 19, 621–635.CrossRefPubMed Guglin, M., Baxi, K., & Schabath, M. (2014). Anatomy of the obesity paradox in heart failure. Heart Failure Reviews, 19, 621–635.CrossRefPubMed
27.
Zurück zum Zitat Jackson, C. E., Haig, C., Welsh, P., Dalzell, J. R., Tsorlalis, I. K., McConnachie, A., Preiss, D., McInnes, I. B., Sattar, N., Petrie, M. C., Gardner, R. S., & McMurray, J. J. (2015). Combined free light chains are novel predictors of prognosis in heart failure. JACC Heart Fail, 3, 618–625.CrossRefPubMed Jackson, C. E., Haig, C., Welsh, P., Dalzell, J. R., Tsorlalis, I. K., McConnachie, A., Preiss, D., McInnes, I. B., Sattar, N., Petrie, M. C., Gardner, R. S., & McMurray, J. J. (2015). Combined free light chains are novel predictors of prognosis in heart failure. JACC Heart Fail, 3, 618–625.CrossRefPubMed
28.
Zurück zum Zitat Apostolakis, S., Lip, G. Y., & Shantsila, E. (2009). Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovascular Research, 85, 649–660.CrossRefPubMed Apostolakis, S., Lip, G. Y., & Shantsila, E. (2009). Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovascular Research, 85, 649–660.CrossRefPubMed
29.
Zurück zum Zitat Rogacev, K. S., Ulrich, C., Blomer, L., Hornof, F., Oster, K., Ziegelin, M., Cremers, B., Grenner, Y., Geisel, J., Schlitt, A., Kohler, H., Fliser, D., Girndt, M., & Heine, G. H. (2010). Monocyte heterogeneity in obesity and subclinical atherosclerosis. European Heart Journal, 31, 369–376.CrossRefPubMed Rogacev, K. S., Ulrich, C., Blomer, L., Hornof, F., Oster, K., Ziegelin, M., Cremers, B., Grenner, Y., Geisel, J., Schlitt, A., Kohler, H., Fliser, D., Girndt, M., & Heine, G. H. (2010). Monocyte heterogeneity in obesity and subclinical atherosclerosis. European Heart Journal, 31, 369–376.CrossRefPubMed
30.
Zurück zum Zitat Sharma, A., Lavie, C. J., Borer, J. S., Vallakati, A., Goel, S., Lopez-Jimenez, F., Arbab-Zadeh, A., Mukherjee, D., & Lazar, J. M. (2015). Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. The American Journal of Cardiology, 115, 1428–1434.CrossRefPubMed Sharma, A., Lavie, C. J., Borer, J. S., Vallakati, A., Goel, S., Lopez-Jimenez, F., Arbab-Zadeh, A., Mukherjee, D., & Lazar, J. M. (2015). Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. The American Journal of Cardiology, 115, 1428–1434.CrossRefPubMed
31.
Zurück zum Zitat Kohlstedt, K., Trouvain, C., Namgaladze, D., & Fleming, I. (2010). Adipocyte-derived lipids increase angiotensin-converting enzyme (ACE) expression and modulate macrophage phenotype. Basic Research in Cardiology, 106, 205–215.CrossRefPubMed Kohlstedt, K., Trouvain, C., Namgaladze, D., & Fleming, I. (2010). Adipocyte-derived lipids increase angiotensin-converting enzyme (ACE) expression and modulate macrophage phenotype. Basic Research in Cardiology, 106, 205–215.CrossRefPubMed
32.
Zurück zum Zitat Wang, P., Mariman, E., Keijer, J., Bouwman, F., Noben, J. P., Robben, J., & Renes, J. (2004). Profiling of the secreted proteins during 3 T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cellular and Molecular Life Sciences, 61, 2405–2417.PubMed Wang, P., Mariman, E., Keijer, J., Bouwman, F., Noben, J. P., Robben, J., & Renes, J. (2004). Profiling of the secreted proteins during 3 T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cellular and Molecular Life Sciences, 61, 2405–2417.PubMed
33.
Zurück zum Zitat Seropian, I. M., Cerliani, J. P., Toldo, S., Van Tassell, B. W., Ilarregui, J. M., Gonzalez, G. E., Matoso, M., Salloum, F. N., Melchior, R., Gelpi, R. J., Stupirski, J. C., Benatar, A., Gomez, K. A., Morales, C., Abbate, A., & Rabinovich, G. A. (2012). Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction. The American Journal of Pathology, 182, 29–40.CrossRefPubMed Seropian, I. M., Cerliani, J. P., Toldo, S., Van Tassell, B. W., Ilarregui, J. M., Gonzalez, G. E., Matoso, M., Salloum, F. N., Melchior, R., Gelpi, R. J., Stupirski, J. C., Benatar, A., Gomez, K. A., Morales, C., Abbate, A., & Rabinovich, G. A. (2012). Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction. The American Journal of Pathology, 182, 29–40.CrossRefPubMed
34.
Zurück zum Zitat Cheng, D. E., Chang, W. A., Hung, J. Y., Huang, M. S., & Kuo, P. L. (2014). Involvement of IL10 and granulocyte colonystimulating factor in the fate of monocytes controlled by galectin1. Molecular Medicine Reports, 10, 2389–2394.PubMed Cheng, D. E., Chang, W. A., Hung, J. Y., Huang, M. S., & Kuo, P. L. (2014). Involvement of IL10 and granulocyte colonystimulating factor in the fate of monocytes controlled by galectin1. Molecular Medicine Reports, 10, 2389–2394.PubMed
35.
Zurück zum Zitat Insenser, M., Montes-Nieto, R., Vilarrasa, N., Lecube, A., Simo, R., Vendrell, J., & Escobar-Morreale, H. F. (2012). A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity. Molecular and Cellular Endocrinology, 363, 10–19.CrossRefPubMed Insenser, M., Montes-Nieto, R., Vilarrasa, N., Lecube, A., Simo, R., Vendrell, J., & Escobar-Morreale, H. F. (2012). A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity. Molecular and Cellular Endocrinology, 363, 10–19.CrossRefPubMed
36.
Zurück zum Zitat Van Aelst, L. N., Voss, S., Carai, P., Van Leeuwen, R., Vanhoutte, D., Sanders-van Wijk, S., Eurlings, L., Swinnen, M., Verheyen, F. K., Verbeken, E., Nef, H., Troidl, C., Cook, S. A., Brunner-La Rocca, H. P., Mollmann, H., Papageorgiou, A. P., & Heymans, S. (2014). Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening. Circulation Research, 116, 425–436.CrossRefPubMed Van Aelst, L. N., Voss, S., Carai, P., Van Leeuwen, R., Vanhoutte, D., Sanders-van Wijk, S., Eurlings, L., Swinnen, M., Verheyen, F. K., Verbeken, E., Nef, H., Troidl, C., Cook, S. A., Brunner-La Rocca, H. P., Mollmann, H., Papageorgiou, A. P., & Heymans, S. (2014). Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening. Circulation Research, 116, 425–436.CrossRefPubMed
37.
Zurück zum Zitat Ahmed, M., Neville, M. J., Edelmann, M. J., Kessler, B. M., & Karpe, F. (2010). Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity (Silver Spring), 18, 27–34.CrossRef Ahmed, M., Neville, M. J., Edelmann, M. J., Kessler, B. M., & Karpe, F. (2010). Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity (Silver Spring), 18, 27–34.CrossRef
38.
Zurück zum Zitat Ahdjoudj, S., Lasmoles, F., Holy, X., Zerath, E., & Marie, P. J. (2002). Transforming growth factor beta2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma. Journal of Bone and Mineral Research, 17, 668–677.CrossRefPubMed Ahdjoudj, S., Lasmoles, F., Holy, X., Zerath, E., & Marie, P. J. (2002). Transforming growth factor beta2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma. Journal of Bone and Mineral Research, 17, 668–677.CrossRefPubMed
39.
Zurück zum Zitat Welch, G. R., Wong, H. L., & Wahl, S. M. (1990). Selective induction of fc gamma RIII on human monocytes by transforming growth factor-beta. Journal of Immunology, 144, 3444–3448. Welch, G. R., Wong, H. L., & Wahl, S. M. (1990). Selective induction of fc gamma RIII on human monocytes by transforming growth factor-beta. Journal of Immunology, 144, 3444–3448.
40.
Zurück zum Zitat Boutten, A., Dehoux, M., Deschenes, M., Rouzeau, J. D., Bories, P. N., & Durand, G. (1992). Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. European Journal of Immunology, 22, 2687–2695.CrossRefPubMed Boutten, A., Dehoux, M., Deschenes, M., Rouzeau, J. D., Bories, P. N., & Durand, G. (1992). Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. European Journal of Immunology, 22, 2687–2695.CrossRefPubMed
Metadaten
Titel
Non classical Monocytes Levels, Increased by Subcutaneous Fat-Secretome, Are Associated with Less Rehospitalization after Heart Failure Admission
verfasst von
Sonia Eiras
Alfonso Varela-Román
Mariléia Cháves Andrade
Ana Castro
Rocío González-Ferreiro
Juan E. Viñuela
Ángel Fernández-Trasancos
Marcos C Carreira
Ezequiel Álvarez
Felipe F Casanueva
José R González-Juanatey
Publikationsdatum
29.12.2016
Verlag
Springer US
Erschienen in
Journal of Cardiovascular Translational Research / Ausgabe 1/2017
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-016-9724-y

Weitere Artikel der Ausgabe 1/2017

Journal of Cardiovascular Translational Research 1/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.